2025
SJR Q3
JCR Q3 · 2,8
205 matched articles
SCIE
Journal detail
Toxicon
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0041010118793150
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,534
- Quartile Q3
- H-Index 154
- Cites/doc 2,8
- Docs (3y) 836
- Cites (3y) 2.393
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,8
- 5Y JIF 2,7
- JCI 0,72
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Toxicology Q3
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,534 | 2,8 | 2,7 | 0,72 | Q2 | 154 |
| 2024 | Q3 | Q3 | 0,527 | 2,4 | 2,5 | 0,7 | Q2 | 148 |
| 2023 | Q3 | Q2 | 0,516 | 2,6 | 2,7 | 0,73 | Q2 | 148 |
| 2022 | Q3 | Q3 | 0,509 | 2,8 | 2,8 | 0,67 | Q2 | 148 |
| 2021 | Q3 | Q3 | 0,497 | 3 | 2,9 | 0,72 | Q2 | 148 |
| 2020 | Q3 | Q3 | 0,561 | 3 | 2,7 | 0,73 | Q2 | 148 |
| 2019 | Q3 | Q3 | 0,522 | 2,2 | 2,2 | 0,79 | Q2 | 148 |
| 2018 | — | Q3 | — | 2,3 | 2,6 | 0,83 | Q2 | — |
| 2017 | Q2 | Q3 | 0,692 | 2,4 | 2,6 | 0,83 | Q2 | 148 |
| 2016 | Q2 | Q3 | 0,766 | 1,9 | 2,4 | — | — | 148 |
| 2015 | Q2 | Q2 | 0,904 | 2,3 | 2,6 | — | — | 148 |
| 2014 | Q2 | Q2 | 0,972 | 2,5 | 2,7 | — | — | 148 |
| 2013 | Q2 | Q2 | 1,022 | 2,6 | 2,8 | — | — | 148 |
| 2012 | Q2 | Q2 | 1,019 | 2,9 | 2,8 | — | — | 148 |
| 2011 | Q2 | Q2 | 0,908 | 2,5 | 2,5 | — | — | 148 |
| 2010 | Q2 | Q2 | 0,872 | 2,5 | 2,7 | — | — | 148 |
| 2009 | — | Q3 | — | 2,1 | 2,4 | — | — | — |
| 2008 | — | Q2 | — | 2,5 | 2,7 | — | — | — |
| 2007 | — | Q2 | — | 2,2 | 2,4 | — | — | — |
| 2006 | — | Q1 | — | 2,5 | — | — | — | — |
| 2005 | — | Q1 | — | 2,3 | — | — | — | — |
| 2004 | — | Q2 | — | 1,9 | — | — | — | — |
| 2003 | — | Q1 | — | 2 | — | — | — | — |
| 2002 | — | Q1 | — | 2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,6 | — | — | — | — |
| 2000 | — | Q2 | — | 1,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,2 | — | — | — | — |
| 1998 | — | Q2 | — | 1,4 | — | — | — | — |
| 1997 | — | Q2 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/356 |
| 2025 | TOXICOLOGY | SCIE | Q3 | Q2 | 60/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 195/352 |
| 2024 | TOXICOLOGY | SCIE | Q3 | Q2 | 68/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/354 |
| 2023 | TOXICOLOGY | SCIE | Q3 | Q2 | 61/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 171/278 |
| 2022 | TOXICOLOGY | SCIE | Q3 | Q3 | 57/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 176/279 |
| 2021 | TOXICOLOGY | SCIE | Q3 | Q2 | 60/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 162/276 |
| 2020 | TOXICOLOGY | SCIE | Q3 | Q3 | 57/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 182/271 |
| 2019 | TOXICOLOGY | SCIE | Q3 | Q3 | 67/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 159/267 |
| 2018 | TOXICOLOGY | SCIE | Q3 | Q3 | 58/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 140/261 |
| 2017 | TOXICOLOGY | SCIE | Q3 | Q2 | 53/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 169/257 |
| 2016 | TOXICOLOGY | SCIE | Q3 | — | 64/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/255 |
| 2015 | TOXICOLOGY | SCIE | Q2 | — | 42/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 115/255 |
| 2014 | TOXICOLOGY | SCIE | Q2 | — | 41/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 106/256 |
| 2013 | TOXICOLOGY | SCIE | Q2 | — | 35/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 80/261 |
| 2012 | TOXICOLOGY | SCIE | Q2 | — | 29/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 109/261 |
| 2011 | TOXICOLOGY | SCIE | Q2 | — | 36/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 115/252 |
| 2010 | TOXICOLOGY | SCIE | Q2 | — | 35/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 129/237 |
| 2009 | TOXICOLOGY | SCIE | Q3 | — | 41/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 96/219 |
| 2008 | TOXICOLOGY | SCIE | Q2 | — | 26/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 97/205 |
| 2007 | TOXICOLOGY | SCIE | Q2 | — | 26/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/199 |
| 2006 | TOXICOLOGY | SCIE | Q1 | — | 18/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 72/193 |
| 2005 | TOXICOLOGY | SCIE | Q1 | — | 18/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 92/187 |
| 2004 | TOXICOLOGY | SCIE | Q2 | — | 29/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 72/185 |
| 2003 | TOXICOLOGY | SCIE | Q1 | — | 18/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 62/188 |
| 2002 | TOXICOLOGY | SCIE | Q1 | — | 17/76 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/186 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 30/78 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 80/181 |
| 2000 | TOXICOLOGY | SCIE | Q2 | — | 30/77 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/175 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 36/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/178 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 24/71 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 85/157 |
| 1997 | TOXICOLOGY | SCIE | Q2 | — | 27/63 |